A novel method for regional citrate anticoagulation in continuous venovenous hemofiltration (CVVHF)

Renal Failure

Volumn 24, Issue 3, 2002, Pages 325-335

  Hofmann, R Michael ^a   Maloney, R N Christine ^a   Ward, David M ^b   Becker, Bryan N ^c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c NONE

Author keywords

Acute renal failure; Citrate anticoagulation; Continuous renal replacement therapy; Hemofiltration

Indexed keywords

CITRIC ACID; HEPARIN; UREA DERIVATIVE; ANTICOAGULANT AGENT;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD FILTRATION; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; FEMALE; HEMOFILTRATION; HUMAN; HYPERCALCEMIA; MALE; PRIORITY JOURNAL; THROMBOCYTOPENIA; CLINICAL TRIAL; COMPARATIVE STUDY; EVALUATION; HOSPITALIZATION; INSTRUMENTATION; INTENSIVE CARE UNIT; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PROSPECTIVE STUDY; TIME; TREATMENT OUTCOME; UNITED STATES; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; ANTICOAGULANTS; BLOOD UREA NITROGEN; CITRIC ACID; COMBINED MODALITY THERAPY; COMPARATIVE STUDY; FEMALE; HEMOFILTRATION; HOSPITAL MORTALITY; HUMAN; INTENSIVE CARE UNITS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; WISCONSIN; HUMANS; MIDDLE AGED;

EID: 0036022131     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-120005366     Document Type: Article

References (22)

1. A comparison of metabolic control by continuous intermittent therapies in acute renal failure
2. Acute dialytic support for the critically ill: Intermittent hemodialysis versus continuous arteriovenous hemodiafiltration
3. Heparin use in continuous renal replacement procedures: The struggle between filter coagulation and patient hemorrhage
4. Extracorporeal management of acute renal failure patients at high risk of bleeding
5. Anticoagulation during continuous renal replacement therapy
6. Nadroparin versus dalteparin anticoagulation in high-voluem, continuous venovenous hemofiltration: A double blind randomized crossover study
7. Anticoagulation in extracorporeal circulation using recombinant hirudin: A case report
8. Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent
9. Hemorrhage during high-risk hemodialysis using controlled heparinization
10. Continuous veno-venous hemofiltration without anticoagulation in high-risk patients
11. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients
12. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding
13. Reducing the hemorrhagic complications of hemodialysis: A controlled comparison of low-dose heparin and citrate anticoagulation
14. Continuous arteriovenous hemofiltration: A report of six months experience
15. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation
16. Regional citrate anticoagulation in continuous venovenous hemodiafiltration
17. Citrate anticoagulation (CIT) for continuous renal replacement therapy (CRRT)
18. Hemostatic alteration during continuous venovenous hemofiltration in acute renal failure
19. The coagulation system in the critically ill patient with acute renal failure and the effect of an extracorporeal circuit
20. Activation of the tissue factor pathway occurs during continuous venovenous hemofiltration
21. Effects of different doses in continuous veno-venous hemofiltration on outcomes of acute renal failure: A prospective randomized trial
22. Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: Dissociation of complement activation and neutropenia from neutrophil degranulation